News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Breast and ovarian cancer linked to thousands of new gene variants
New research identifies specific genetic changes that can increase someone's risk of breast and ovarian cancers, to help guide clinical decision-making
ESMO 2024: More than half of advanced melanoma patients treated with combination immunotherapy survive the disease for at least 10 years
More than half of people diagnosed with advanced melanoma are now surviving the disease for ten years or more when they receive a combination immunotherapy treatment, according to a study led by researchers from the ICR and The Royal Marsden.
New drug target discovered for aggressive form of prostate cancer
Scientists have discovered that a protein linked to prostate cancer is associated with more aggressive disease – it could be a new target for treatment and used to help predict who will become resistant to hormone therapy.
ESMO 2024: Routine MRI scans detect cancers in asymptomatic patients with rare genetic condition
A study has found that people with Li-Fraumeni syndrome would benefit from yearly whole-body MRI scans to screen for cancers.
Improved breast cancer risk tools on the horizon as major study reaches 20-year halfway point
Scientists are developing breast cancer risk tools that will help to identify women at high risk, even if they do not have a family history of the disease, thanks to one of the world’s largest and longest-running studies into the causes of breast cancer.
Potential new drug to target rare childhood brain tumour
Ribociclib – a drug already used to treat breast cancer – may help slow the growth of diffuse hemispheric glioma (DHG), new research has found.
New method could lower radiotherapy doses for some cancer patients
A special type of MRI scan where patients inhale 100% oxygen could result in lower radiotherapy doses for some cancer patients.
ICR welcomes protein degradation expert to lead centre aimed at discovering new ways to treat cancer
Dr Zoran Rankovic has been appointed to direct the pioneering Centre for Protein Degradation at The Institute of Cancer Research (ICR).
Ground-breaking study reveals previously unknown genetic causes of colorectal cancer
Cancers develop partly through genetic abnormalities within cells of the body. Colorectal cancer is a major cause of death worldwide, but we don’t yet have a full understanding of the genetic changes that cause it to grow. New research – published today in Nature – delivers an unprecedented view of the genetic landscape of CRC and its responses to treatment.
Cancer cells pretend to be ‘super fit’ to outsmart normal cells and invade the body
Scientists have discovered that some cancer cells pretend to be ‘super fit’ to fool normal healthy cells into giving them their nutrients, allowing them to expand and spread around the body.
MHRA approves first-in-class breast cancer drug
The Institute of Cancer Research, London, welcomes the news that a new targeted breast cancer drug, capivasertib, has been approved by the Medicines & Healthcare products Regulatory Agency (MHRA) for treating the most common type of advanced breast cancer.
More men with advanced prostate cancer could be successfully treated with precision drug olaparib
Scientists have discovered a genetic aberration found in some prostate cancers that could allow more men to be successfully treated with targeted drug olaparib
